Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for Philadelphia-positive myelogenous leukemia has been reported in the published literature.
No clinical trials have been registered for Philadelphia-positive myelogenous leukemia.
24 publications have been identified in PubMed for Philadelphia-positive myelogenous leukemia. Research spans Case Report / Case Series (25%), Epidemiology / Natural History (21%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 25% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:01 AM UTC
Common questions about Philadelphia-positive myelogenous leukemia
Disease patterns and progression
5 |
21% |
Laboratory research | 4 | 17% |
Research summaries | 3 | 13% |
Clinical study results | 3 | 13% |
New treatment approaches | 2 | 8% |
Testing and diagnosis research | 1 | 4% |
Kantarjian H (2026). [PMID: 41761287](https://pubmed.ncbi.nlm.nih.gov/41761287/). *American journal of hematology*. [Review / Meta-Analysis]
Işik S (2026). [PMID: 41816740](https://pubmed.ncbi.nlm.nih.gov/41816740/). *Turkish journal of medical sciences*. [Case Report / Case Series]
Sy SKB (2026). [PMID: 41670862](https://pubmed.ncbi.nlm.nih.gov/41670862/). *Clinical pharmacokinetics*. [Clinical Trial Publication]
Goulart H (2026). [PMID: 41915597](https://pubmed.ncbi.nlm.nih.gov/41915597/). *Acta Haematol*. [Case Report / Case Series]
Mohty R (2026). [PMID: 41954351](https://pubmed.ncbi.nlm.nih.gov/41954351/). *Leuk Lymphoma*. [Basic Science / Preclinical]
Yokoyama S (2026). [PMID: 42020684](https://pubmed.ncbi.nlm.nih.gov/42020684/). *Int J Hematol*. [Epidemiology / Natural History]
Ahmed A (2026). [PMID: 42152197](https://pubmed.ncbi.nlm.nih.gov/42152197/). *J Coll Physicians Surg Pak*. [Epidemiology / Natural History]
Zafar F (2025). [PMID: 40395267](https://pubmed.ncbi.nlm.nih.gov/40395267/). *Cureus*. [Epidemiology / Natural History]
Punatar S (2025). [PMID: 40486077](https://pubmed.ncbi.nlm.nih.gov/40486077/). *Blood cell therapy*. [Basic Science / Preclinical]
Ferrari A (2025). [PMID: 41009384](https://pubmed.ncbi.nlm.nih.gov/41009384/). *International journal of molecular sciences*. [Diagnostic / Biomarker]